Lanean...

Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?

Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease for which therapeutic advances in immunosuppressive and support therapy have significantly improved survival over the last 5 decades. Unfortunately, SLE still carries substantially increased rates of mortality and end stage renal di...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Discov Med
Egile Nagusiak: Calero, Ismael, Sanz, Iñaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4557964/
https://ncbi.nlm.nih.gov/pubmed/21122473
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!